BioSpace News Archive

ROSA Partial Knee System Expands Zimmer Biomet’s Robotics Portfolio and Adds to the ZBEdge Connected Intelligence Suite

IceCure Medical Ltd. (TASE: ICCM) (“IceCure” or the “Company”), announced that updated clinical data from its ICE3 clinical trial of ProSense® for the treatment of small, low-risk, early-stage malignant breast tumors will be presented in an oral presentation at the American Society of Breast Surgeons (ASBrS) Annual Meeting

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Company will host a webcast conference call to report its first quarter 2021 financial results and provide an update on the company’s business and outlook on Tuesday, May 4, 2021 at 4:30 p.m. (ET) after the closing of the market.

On April 10th, leading manufacturer of medical and aesthetic lasers and light source technologies, Sciton Inc., hosted over 650 medical professionals at its 2021 Rockstars of Aesthetics Virtual Summit.

Ripple Therapeutics Corporation a clinical stage, ophthalmology-focused developer of novel pharmaceuticals, announced today that the first patient has been treated in RIPPLE-1, a Phase II trial evaluating IBE-814 IVT, a proprietary intravitreal dexamethasone implant targeting inflammatory retinal diseases.

eSupport provides mental-health services developed by experts and grounded in science for people with chronic conditions.

Advanced BioMatrix launches CytoSoft® T-25 and T-75 Flasks to completely upend traditional cell culture and cell expansion. CytoSoft® flasks contain a thin layer of biocompatible silicone formulated to a specific stiffness including 0.2, 0.5, 2, 8, 16, 32, and 64 kPa

Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that its DILIsym Services (DSS) division has renewed licenses to its DILIsym® software platform, its flagship quantitative systems toxicology (QST) software for predicting and investigating drug-induced liver injury (DILI), for use by the U.S. Food and Drug Administration (FDA).

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that it will host a live webcast of its second quarter fiscal 2021 conference call on Wednesday, April 28, at 7:30 a.m. CT (8:30 a.m. ET).

Varex Imaging Corporation (Nasdaq: VREX) today announced that it will report unaudited financial results for the second quarter of fiscal year 2021 following the close of regular trading on Tuesday, May 4, 2021. The earnings news release will be followed by a conference call at 3:00 p.m. Mountain Time that day.